Related Experiment Video
Updated: May 9, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
A quantitative system pharmacology computer model for cognitive deficits in schizophrenia
H Geerts1, P Roberts, A Spiros
11] In Silico Biosciences, Berwyn, Pennsylvania, USA [2] Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
This study developed a computational model to predict cognitive improvements in schizophrenia, addressing limitations of current treatments for working memory deficits. The model aids in developing new therapies and increasing clinical trial success rates.
Area of Science:
- Neuroscience
- Computational Psychiatry
- Pharmacometrics
Background:
- Current antipsychotics effectively manage positive symptoms of schizophrenia but fail to address cognitive impairments.
- The Matrics initiative identified targets for cognitive dysfunction, yet clinical translation has yielded limited success.
- Cognitive deficits, particularly in working memory, significantly impact schizophrenia patient outcomes.
Purpose of the Study:
- To develop a mechanism-based, humanized computational model of a cortical brain network implicated in working memory (WM) maintenance in schizophrenia.
- To validate the model using clinical data from N-back WM tests.
- To simulate the effects of GABA modulators and drug augmentation strategies to predict cognitive outcomes.
Main Methods:
- Developed a humanized computational model of a key cortical brain network involved in WM maintenance.
- Calibrated the model using published clinical data from N-back working memory tests.
- Simulated the effects of lorazepam, flumazenil, and clozapine-risperidone augmentation to assess predictive capacity.
Main Results:
- The model successfully simulated the effects of GABA modulators (lorazepam, flumazenil) on working memory.
- The model predicted outcomes for a clozapine-risperidone augmentation trial, demonstrating its capacity for polypharmacy simulation.
- The humanized computational approach provides a quantitative method for assessing cognitive outcomes in CNS drug development.
Conclusions:
- A mechanism-based humanized computational model can accurately predict cognitive outcomes in schizophrenia.
- This approach offers a valuable tool for early-stage assessment in CNS research and development.
- The model has the potential to improve the success rate of clinical trials for cognitive impairments in schizophrenia.
More Related Videos
16:23Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
Published on: February 26, 2014
09:33Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Related Concept Videos
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Overview of Compartment Models